The firm is expanding its melanoma portfolio while launching new trials of T-cell receptor therapies in oncology, infectious disease, and autoimmune disease.

A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor ...

Radiation testing suggests that solar cells made from carbon-based, or organic, materials could outperform conventional ...

Russell W. Jenkins, MD, PhD, a physician investigator in the Krantz Family Center for Cancer Research at the Mass General ...